Conditional Tetracycline–Regulated Expression of Tgf–β1 in Liver of Transgenic Mice Leads to Reversible Intermediary Fibrosis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Based on the tetracycline–regulated gene expression system, a double–transgenic mouse model for liver fibrosis was established in which the expression of transforming growth factor β1 (TGF–β1) can be regulated deliberately by addition or removal of doxycycline hydrochloride to the drinking water. TGF–β1 plasma levels in induced double–transgenic mice reached values ranging from 250 to 1,200 ng/mL, being 10 to 30 times above the normal plasma levels. By applying a cyclic induction–deinduction protocol, deleterious effects of the high plasma TGF–β1 levels were overcome. By using this protocol, liver fibrosis occurred within a few cycles and progressed further to an intermediary fibrosis when cyclic induction was continued. On histochemical staining, a marked perisinusoidal deposition of extracellular matrix was detected accompanied by the activation of hepatic stellate cells as shown by alpha–smooth muscle actin (α–SMA) expression. Apoptosis of hepatocytes was prominent in TGF–β1 high producers, leading to a decreasing number of TGF–β1–expressing cells with time. No compensatory proliferation of hepatocytes could be detected. In advanced stages, fibrogenesis could be stopped by switching off TGF–β1 production and reversal of fibrosis could be shown by (immuno)histochemistry within 6 to 21 days. Determination of messenger RNA (mRNA) levels of procollagen I and III, laminin (B1), matrix metalloproteinase (MMP)–2, –9, and –13, and tissue inhibitor of matrix metalloproteinase (TIMP)–1 and –2 by real–time reverse–transcription polymerase chain reaction (RT–PCR) provided insight into some mechanistic details of the fibrogenic process and its reversal. In conclusion, this model will enable the analysis of fibrogenesis at progressive stages and help in elucidating the cellular changes during development and regression of liver fibrosis caused by elevated TGF–β1 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Self-citationIredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Tetracyclines in the control of gene expression in eukaryotes
Gossen, M., & Bujard, H. (2001) · Tetracyclines in Biology, Chemistry and Medicine · doi:10.1007/978-3-0348-8306-1_5 · Cited by 29
Self-citation
Cited by
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
TGF-β signaling in health, disease and therapeutics
Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,168
Gressner, A. M., & Weiskirchen, R. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00292.x · Cited by 718
“Conditionally regulated expression of TGF-β further reveals that the induction of fibrogenesis is directly linked to the concentration of this causative agent [41].”
BackgroundTGF-β in progression of liver disease
Dooley, S., & ten Dijke, P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1246-y · Cited by 718
“…target for active TGF-β in CLD. Results of experiments in which TGF-β is misexpressed in liver by using adenovirus or transgenic TGF-β mice have revealed an important contribution of TGF-β to HSC activation and fibrogenesis (Kanzler et al. 1999; Hellerbrand et al. 1999; Ueberham et al. 2003).”
BackgroundHepatic fibrosis: concept to treatment
Trautwein, C., Friedman, S. L., Schuppan, D., & Pinzani, M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.039 · Cited by 677
Metadata
- Authors
- Ueberham, E., Löw, R., Ueberham, U., Schönig, K., Bujard, H., & Gebhardt, R.
- Venue
- Hepatology
- Published
- 2003-05
- Volume
- 37
- Issue
- 5
- Pages
- 1067-1078
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1987301388
- Cited by
- 150
- References
- 3
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Conditional Tetracycline–Regulated Expression of Tgf–β1 in Liver of Transgenic Mice Leads to Reversible Intermediary Fibrosis. https://app.cochat.ai/papers/10.1053/jhep.2003.50196
- The paper
- Ueberham, E., Löw, R., Ueberham, U., Schönig, K., Bujard, H., & Gebhardt, R. (2003). Conditional Tetracycline–Regulated Expression of Tgf–β1 in Liver of Transgenic Mice Leads to Reversible Intermediary Fibrosis. Hepatology. https://doi.org/10.1053/jhep.2003.50196
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.